Bioventus Inc. (BVS)

Bioventus Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 16, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	531	686	332	162	861	-
Market Cap Growth	-22.62%	106.84%	105.22%	-81.23%	-	-
Enterprise Value	830	1,086	775	605	1,054	-
Last Close Price	7.93	10.50	5.27	2.61	14.49	-
Forward PE	10.43	20.00	21.82	17.17	21.50	-
PS Ratio	0.93	1.20	0.65	0.32	2.00	-
PB Ratio	3.20	3.70	1.50	0.39	1.61	-
P/FCF Ratio	9.93	18.16	41.57	-	90.94	-
P/OCF Ratio	9.48	17.69	21.63	-	37.46	-
PEG Ratio	-	-	-	-	2.07	-
EV/Sales Ratio	1.47	1.90	1.51	1.18	2.45	-
EV/EBITDA Ratio	12.58	18.42	26.88	-	25.38	-
EV/EBIT Ratio	17.06	27.27	382.69	-	50.07	-
EV/FCF Ratio	15.52	28.75	97.14	-	111.28	-
Debt / Equity Ratio	1.65	1.92	1.90	1.06	0.71	1.42
Debt / EBITDA Ratio	4.81	5.50	11.81	719.64	8.23	3.83
Debt / FCF Ratio	6.38	9.42	52.70	-	39.72	3.70
Asset Turnover	0.77	0.75	0.47	0.39	0.50	0.66
Inventory Turnover	1.95	2.01	2.09	2.47	2.82	3.11
Quick Ratio	1.07	0.80	0.91	0.55	0.93	1.43
Current Ratio	1.74	1.31	1.53	0.90	1.46	1.73
Return on Equity (ROE)	6.38%	-21.55%	-38.27%	-30.58%	3.38%	10.16%
Return on Assets (ROA)	4.13%	3.24%	0.12%	-1.67%	1.53%	2.82%
Return on Capital (ROIC)	5.33%	4.21%	0.17%	-2.46%	2.09%	3.84%
Return on Capital Employed (ROCE)	9.00%	7.70%	0.30%	-3.20%	2.00%	5.90%
Earnings Yield	1.92%	-4.89%	-47.08%	-98.15%	2.25%	-
FCF Yield	10.07%	5.51%	2.40%	-15.50%	1.10%	-
Payout Ratio	-	-	-	-	-	121.18%
Buyback Yield / Dilution	-6.27%	-3.03%	-2.05%	-35.00%	-828.01%	-

Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q